Strides Pharma Inc. has recalled 396 50-count bottles of Methoxsalen Capsules, USP 10mg (methoxsalen) because the medication failed to meet required dissolution standards. This defect means the capsules may not dissolve correctly in the body, which could prevent the drug from working as intended or cause inconsistent levels of the medication in the bloodstream. These prescription capsules were distributed nationwide in the USA to pharmacies and other distributors. If you have this medication, you should consult your doctor or pharmacist about your treatment.
Failed dissolution means the medication may not release properly after ingestion, potentially leading to ineffective treatment of the patient's condition. No injuries or adverse incidents have been reported in connection with this recall.
You have 2 options:
Recall #: D-0260-2024; Manufactured by Strides Pharma Science Ltd. in Bengaluru, India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.